These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3449315)

  • 1. Effect of age on the sensitivity of cell cultures to Clostridium difficile toxin.
    Tichota-Lee J; Jaqua-Stewart MJ; Benfield D; Simmons JL; Jaqua RA
    Diagn Microbiol Infect Dis; 1987 Dec; 8(4):203-14. PubMed ID: 3449315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Clostridium difficile cytotoxin in HEp-2 and CHO cell lines.
    Murray PR; Weber CJ
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):331-3. PubMed ID: 6667607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of gas-liquid chromatography as a screening test for toxigenic Clostridium difficile in diarrhoeal stools.
    Pepersack F; Labbe M; Nonhoff C; Schoutens E
    J Clin Pathol; 1983 Nov; 36(11):1233-6. PubMed ID: 6630574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Clostridium difficile toxin in various tissue culture monolayers.
    Maniar AC; Williams TW; Hammond GW
    J Clin Microbiol; 1987 Oct; 25(10):1999-2000. PubMed ID: 3667920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latex agglutination test for detection of Clostridium difficile toxin in stool samples.
    Shahrabadi MS; Bryan LE; Gaffney D; Coderre SE; Gordon R; Pai CH
    J Clin Microbiol; 1984 Sep; 20(3):339-41. PubMed ID: 6490824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children.
    Wolfhagen MJ; Meijer K; Fluit AC; Torensma R; Bruinsma RA; Fleer A; Verhoef J
    Gut; 1994 Nov; 35(11):1608-12. PubMed ID: 7828982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
    Feltis BA; Garni RM; Wells CL
    J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of semi-quantitative cultures in the diagnosis of Clostridium difficile associated disease.
    Poirier L; Lamothe F; Vincelette J; Bourgault AM
    Eur J Clin Microbiol Infect Dis; 1991 Sep; 10(9):770-2. PubMed ID: 1810735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile toxin in faecal specimens of healthy children and children with diarrhoea.
    Mårdh PA; Helin I; Colleen I; Oberg M; Holst E
    Acta Paediatr Scand; 1982 Mar; 71(2):275-8. PubMed ID: 7136636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bacterial isolation, cytotoxicity assay, and counterimmunoelectrophoresis for the detection of Clostridium difficile and its toxin.
    Jarvis W; Nunez-Montiel O; Thompson F; Dowell V; Towns M; Morris G; Hill E
    J Infect Dis; 1983 Apr; 147(4):778. PubMed ID: 6842010
    [No Abstract]   [Full Text] [Related]  

  • 11. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.
    Borriello SP; Barclay FE; Reed PJ; Welch AR; Brown JD; Burdon DW
    J Clin Pathol; 1987 May; 40(5):573-80. PubMed ID: 3108333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridial toxins in neonatal necrotising enterocolitis.
    Thomas DF; Fernie DS; Bayston R; Spitz L
    Arch Dis Child; 1984 Mar; 59(3):270-2. PubMed ID: 6324700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADP-ribosylation in Clostridium difficile toxin-treated cells is not related to cytopathogenicity of toxin B.
    Florin I; Thelestam M
    Biochim Biophys Acta; 1991 Jan; 1091(1):51-4. PubMed ID: 1995067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A.
    Torres JF
    J Med Microbiol; 1991 Jul; 35(1):40-4. PubMed ID: 1906544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxin A of Clostridium difficile is a potent cytotoxin.
    Tucker KD; Carrig PE; Wilkins TD
    J Clin Microbiol; 1990 May; 28(5):869-71. PubMed ID: 2112562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and release of toxins A and B by Clostridium difficile.
    Ketley JM; Haslam SC; Mitchell TJ; Stephen J; Candy DC; Burdon DW
    J Med Microbiol; 1984 Dec; 18(3):385-91. PubMed ID: 6389875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of CIE for the detection of Clostridium difficile toxin in stool filtrates: laboratory and clinical correlation.
    Kurzynski TA; Cembrowski GS; Kimball JL
    Am J Clin Pathol; 1983 Mar; 79(3):370-4. PubMed ID: 6829506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of culture, cytotoxicity assays, and enzyme-linked immunosorbent assay for toxin A and toxin B in the diagnosis of Clostridium difficile-related enteric disease.
    Walker RC; Ruane PJ; Rosenblatt JE; Lyerly DM; Gleaves CA; Smith TF; Pierce PF; Wilkins TD
    Diagn Microbiol Infect Dis; 1986 May; 5(1):61-9. PubMed ID: 3086027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.
    Rüssmann H; Panthel K; Bader RC; Schmitt C; Schaumann R
    Eur J Clin Microbiol Infect Dis; 2007 Feb; 26(2):115-9. PubMed ID: 17211606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.